

[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI

[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
[ Wed, Feb 21st 2024
] - WOPRAI
Colin Bristow Downgraded (BTAI) to Hold and Decreased Target to $4 on, Feb 21st, 2024
Colin Bristow of UBS, Downgraded "BioXcel Therapeutics, Inc." (BTAI) to Hold and Decreased Target from $9 to $4 on, Feb 21st, 2024.
Colin has made no other calls on BTAI in the last 4 months.
There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Colin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Colin
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $11 on, Wednesday, November 15th, 2023
Contributing Sources